InvestSMART

Regis Healthcare Limited (ASX: REG) - Announcements

Current share price for REG : $4.360 0.07 (1.58%)+

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,319 Regis Healthcare - Results of Annual General Meeting 25 Oct 2022 4:03PM $1.880 $4.360 risen by 131.91%
$1,319 Chairman and MD Addresses and Presentation to AGM 25 Oct 2022 9:37AM $1.840 $4.360 risen by 136.96%
$1,319 Change Of Director's Interest Notice 28 Sep 2022 9:15AM $1.720 $4.360 risen by 153.49%
$1,319 Application for quotation of securities - REG 27 Sep 2022 4:49PM $1.720 $4.360 risen by 153.49%
$1,319 Notice of Annual General Meeting/Proxy Form 21 Sep 2022 8:48AM $1.800 $4.360 risen by 142.22%
$1,319 Annual Report to shareholders 12 Sep 2022 1:07PM $1.915 $4.360 risen by 127.68%
$1,319 Appendix 4G and Corporate Governance Statement 12 Sep 2022 12:58PM $1.920 $4.360 risen by 127.08%
$1,319 Notification of cessation of securities - REG 30 Aug 2022 12:52PM $2.110 $4.360 risen by 106.64%
$1,319 Regis Healthcare Investor Presentation FY2022 Results 24 Aug 2022 9:04AM $2.040 $4.360 risen by 113.73%
$1,319 Regis Healthcare Results Announcement FY2022 24 Aug 2022 9:02AM $2.040 $4.360 risen by 113.73%
$1,319 Regis Healthcare Appendix 4E and Financial Report FY2022 24 Aug 2022 9:01AM $2.040 $4.360 risen by 113.73%
$1,319 Dividend/Distribution - REG 24 Aug 2022 8:41AM $2.040 $4.360 risen by 113.73%
$1,319 AGM Date 15 Aug 2022 11:08AM $2.280 $4.360 risen by 91.23%
$1,319 Notification of FY22 Full Year Results Date 11 Jul 2022 11:50AM $1.855 $4.360 risen by 135.04%
$1,319 COVID-19 Cost Impacts and Status of Government Grants 16 May 2022 9:22AM $2.280 $4.360 risen by 91.23%
$1,319 Oneview Litigation 14 Apr 2022 11:23AM $2.130 $4.360 risen by 104.69%
$1,319 ONE: Settlement of Legal Dispute with Regis 14 Apr 2022 9:55AM $2.130 $4.360 risen by 104.69%
$1,319 Ceasing to be a substantial holder from MQG 6 Apr 2022 10:47AM $2.060 $4.360 risen by 111.65%
$1,319 Becoming a substantial holder from MQG 31 Mar 2022 6:30PM $2.160 $4.360 risen by 101.85%
$1,319 Regis Healthcare Results Announcement 1H FY22 23 Feb 2022 8:27AM $1.930 $4.360 risen by 125.91%
$1,319 Dividend/Distribution - REG 23 Feb 2022 8:27AM $1.930 $4.360 risen by 125.91%
$1,319 Regis Healthcare Investor Presentation 1H FY22 Results 23 Feb 2022 8:25AM $1.930 $4.360 risen by 125.91%
$1,319 Regis Healthcare 4D And Financial Report 1H FY22 23 Feb 2022 8:23AM $1.930 $4.360 risen by 125.91%
$1,319 Initial Director's Interest Notice 19 Jan 2022 8:46AM $1.820 $4.360 risen by 139.56%
$1,319 Appointment of Non-executive Director and Operations Update 17 Jan 2022 9:49AM $1.820 $4.360 risen by 139.56%

176 - 200 of 406 results

Page 8 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.